PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

Fast-growing lung-health AI startup strengthens executive team with business leader experienced in medical devices for lung cancer diagnosis. Jason Pesterfield was previously CEO at Veran Medical Technologies, growing it through…

Continue ReadingPRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

Rapidly growing lung health startup aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software. OXFORD, UK / HOUSTON, USA – August 18, 2021: Optellum,…

Continue ReadingPRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…

Continue ReadingAI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

European consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung nodule malignancy. As discussed in earlier news stories, there has…

Continue ReadingEuropean consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

PRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology

Oxford-based company Optellum, supported by NHS collaborations and grant funding, launches the world’s first AI decision support for early lung cancer • Ground-breaking machine-learning neural network can recognise the signs…

Continue ReadingPRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology

US PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States. Oxford, United Kingdom – March 23,…

Continue ReadingUS PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

Optellum named by the UK government as one of the top 100 digital health companies

Healthcare UK, part of the Department for International Trade (DIT), has launched a programme to showcase the UK's leading digital health companies.  Digital Health and Artificial Intelligence is seen as the answer to many of the challenges facing global…

Continue ReadingOptellum named by the UK government as one of the top 100 digital health companies